Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Bullboard (OTCQX:MRVFF)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
Comment by beenthereon Jun 30, 2019 8:00pm

RE:Nuvo Research Inc

Ha! Ha! Ha! I got you beat by a country mile!! lol I bought my first 1000 shares in March 2000 for $12.50! And they did one reverse split if I remember correctly at 62 to 1! You do the math! After ...more  
173
Discussion
Post by Itdontmatteron Jun 23, 2019 8:07pm

Nuvo Research Inc

July, 2016 this was a $7.00 stock.
183
Discussion
Post by runmyownlifeon Jun 18, 2019 3:40pm

Competence

When negotiating debt with Deerfield a few months ago and knowing the source of funding to repay the debt was subject to risk (court case), would not a competent manager structure a contingency at the ...more  
176
Post by ValueCapon Jun 18, 2019 10:47am

Bloom Burton Raises Valuation Model

Keeps target the same at 2.50 until synergies start to be realized without impacting topline https://www.bloomburton.com/research/NRI20190618.pdf
114
Post by ValueCapon Jun 17, 2019 5:00pm

Certainly no bankruptcy. And some more good news

Cost synergies to save 7 million. Blexten growing at 72% over last year in high allergy season. Cambia up 33%.  Deerfield allowing for deferral mechanism at Nuvo’s discretion if Vimovo US loses ...more  
146
Post by lscfaon Jun 17, 2019 8:19am

Synergies

$7 million in annual savings => $0.12 eps....... “Nuvo has identified synergies within the combined business and is making organizational changes that the Company believes will reduce its ...more  
154
Comment by lscfaon Jun 12, 2019 2:54pm

RE:RE:RE:RE:Oh how the mighty have fallen...

Get frigging real. PLI was not generating positive cash flow, NRI is.......
150
Discussion
Comment by consultant99on Jun 10, 2019 6:20pm

RE:RE:Oh how the mighty have fallen...

Bankrupcy? Perhaps but ultimately if the loan is not repaid the leader converts to shares and there is massive dilution. Ultimately shareholders get the same treatment - pennies on the dollar. This ...more  
147
Discussion
Comment by ValueCapon Jun 06, 2019 6:07pm

RE:Oh how the mighty have fallen...

Thats all great history, but the question is, is there value here at this price? If these guys arent going bankrupt - which doesnt make sense with the current business - then there at least is some ...more  
140
Discussion
Comment by lscfaon Jun 06, 2019 4:12pm

RE:Notice Of annual Meeting of Share -- Compensation

Vote against all the compensation proposals and the whole damn board.....
83
Discussion
Post by Spuds21on Jun 06, 2019 2:51pm

Notice Of annual Meeting of Share -- Compensation

Really - Read the Notice - All about compensation... for what exactly?  Election of directors? Base Salary ?  Maternity Leave ?  The company share price has been destroyed...  ...more  
126
Discussion
Post by consultant99on Jun 06, 2019 1:20pm

Oh how the mighty have fallen...

$1 invested in Nuvo at the time of the spin-off vote is now worth $0.21 Nuvo which held the profitable Pennsaid franchise is now worth 43% of the value remaining. Bloom Burton was favourable to the ...more  
167
Discussion
Comment by ValueCapon May 31, 2019 5:33pm

RE:RE:Market Cap hit 6.6 Million today

12 month target 2.50. $.70 to 2.50... there’s a return.  https://www.bloomburton.com/research/NRI20190516.pdf
129
Discussion
Comment by Marathon11on May 31, 2019 2:02pm

RE:Market Cap hit 6.6 Million today

You are correct. Based on what we know, this is hugely oversold. Definitely some serious manipulation to accumulate in my opinion. What was Bloom Burton's revised 12 month target?
132
Discussion
Comment by runmyownlifeon May 31, 2019 1:45pm

RE:Market Cap hit 6.6 Million today

Not wrong. Perhaps optimistic that management can execute on sales (historical a huge competency gap) to maintain current levels. And optimistic that management can manage expenses (also a competency ...more  
96
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities